Larvol Delta - Aligos-Therapeutics-Announces-the-Completion-of-Enrollment-in-the-ALG055009-Phase-2a-HERALD-Study-for-the-Treatment-of-MASH

ALG-055009 - Aligos Therap

https://www.globenewswire.com/news-release/2024/05/21/2885520/0/en/Aligos-Therapeutics-Announces-the-Completion-of-Enrollment-in-the-ALG-055009-Phase-2a-HERALD-Study-for-the-Treatment-of-MASH.html

May 21, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next